Comparative Genomic Hybridization Analysis Reveals New Different Subgroups in Early-stage Bladder Tumors

Urology

Volumn 75, Issue 2, 2010, Pages 347-355

  Prat, Esther ^a   del Rey, Javier ^a   Ponsa, Immaculada ^a   Nadal, Marga ^b   Camps, Jordi ^a   Plaja, Alberto ^c   Campillo, Mercedes ^d   Algaba, Ferran ^e   Gelabert, Antoni ^f   Miró, Rosa ^a  

^a Institut de Biotecnologia i Biomedicina   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e FUNDACIÓ PUIGVERT   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME LOSS; CHROMOSOME XP; CHROMOSOME XQ; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 75349094025     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.04.080     Document Type: Article

References (28)

1. Knowles M.A. The genetics of transitional cell carcinoma: progress and potential clinical application. BJU Int 84 (1999) 412-427
2. Spruck III C.H., Ohneseit P.F., Gonzalez-Zulueta M., et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54 (1994) 784-788
3. van Rhijn B.W.G., Lurkin I., Radvanyi F., et al. The fibroblast growth factor. Receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 61 (2001) 1265-1268
4. Höglund M., Sall T., Heim S., et al. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res 61 (2001) 8241-8246
5. Mhawech-Fauceglia P., Cheney R.T., and Schwaller J. Genetic alterations in urothelial bladder carcinoma. Cancer 106 (2006) 1205-1216
6. Kallioniemi A., Kallioniemi O.P., Citro G., et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12 (1995) 213-219
7. Simon R., Burger H., Semjonow A., et al. Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 17 (2000) 1025-1029
8. Zhao J., Richter J., Wagner U., et al. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 59 (1999) 4658-4661
9. Richter J., Wagner U., Schraml P., et al. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59 (1999) 5687-5691
10. Prat E., Bernués M., Caballín M.R., et al. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 57 (2001) 986-992
11. Czerniak B., Li L., Chaturvedi V., et al. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 27 (2000) 392-402
12. Hurst C.D., Fiegler H., Carr P., et al. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23 (2004) 2250-2263
13. Veltman J.A., Fridlyand J., Pejavar S., et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63 (2003) 2872-2880
14. Blaveri E., Brewer J.L., Roydasgupta R., et al. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11 (2005) 7012-7022
15. Heidenblad M., Lindgren D., Jonson T., et al. Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors. BMC Med Genomics 31 (2008) 1-3
16. Kim W.J., and Bae S.C. Molecular biomarkers in urothelial bladder cancer. Cancer Sci 99 (2008) 646-652
17. Sánchez-Carbayo M., and Cordon-Cardó C. Molecular alterations associated with bladder cancer progression. Semin Oncol 34 (2007) 75-84
18. Sánchez-Carbayo M., Socci N.D., Lozano J.J., et al. Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 163 (2003) 505-516
19. Dyrskjot L., Thykjaer T., Kruhoffer M., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33 (2003) 90-96
20. Blaveri E., Simko J.P., Korkola J.E., et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11 (2005) 4044-4055
21. World Health Organization. Histological typing of urinary bladder tumors. Geneva (1973)
22. Union Internacional Contre le Cancer: TNM classification of malignant tumors (1978) Geneva
23. Richter J., Jiang F., Gorog J.P., et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57 (1997) 2860-2864
24. Eble J.N., Sauter G., Epstein J.I., et al. Tumours of the urinary system and male genital organs. Lyon, World Health Organization classification of tumours (2004)
25. Junker K., van Oers J.M., Zwarthoff E.C., et al. Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations. Neoplasia 10 (2008) 1-7
26. Camps J., Ponsa I., Ribas M., et al. Comprehensive measurement of chromosomal instability in cancer cells: combination of fluorescence in situ hybridization and cytokinesis-block micronucleus assay. FASEB J 19 (2005) 828-830
27. Höglund M., Gisselsson D., Mandahl N., et al. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31 (2001) 156-171
28. Camps J., Morales C., Prat E., et al. Genetic evolution in colon cancer KM12 cells and metastatic derivates. Int J Cancer 110 (2004) 869-874